Immunological Compatibility of Advanced Nanotherapeutics: Mechanistic Insights & Clinical Translation
Time: 12:15 pm
day: Day One
Details:
- Understanding how nanoparticle properties like size, charge, and composition drive immune activation pathways to enable the design of safer, more targeted nanomedicines
- Leveraging advanced metabolic and immunotoxicity assays, backed by harmonised protocols (ASTM, EUNCL, IDDC), to ensure reliable data and facilitate regulatory approval
- Gaining translational insights from LNP vaccine case studies and global regulatory contributions, helping accelerate product development and build confidence in emerging
- formulations
